{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:05:09Z","timestamp":1791266709664,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fondazione Umberto Veronesi,Italy"},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancerfonden,Sweden","award":["21 1861 Pj 01 H"],"award-info":[{"award-number":["21 1861 Pj 01 H"]}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["24 3883 Pj 01 H"],"award-info":[{"award-number":["24 3883 Pj 01 H"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["30307"],"award-info":[{"award-number":["30307"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-025-00659-2","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:31:05Z","timestamp":1749169865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Affibodies as valuable tool to prevent \u03b22m aggregation under lysosomal-like conditions"],"prefix":"10.1186","volume":"20","author":[{"given":"Cristina","family":"Visentin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Hotot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipambita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Gr\u00e4slund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ricagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"659_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13506129.2024.2405948","volume":"31","author":"JN Buxbaum","year":"2024","unstructured":"Buxbaum JN, Eisenberg DS, F\u00e4ndrich M, McPhail ED, Merlini G, Saraiva MJM, Sekijima Y, Westermark P. Amyloid nomenclature 2024: update, novel proteins, and recommendations by the international society of amyloidosis (ISA) nomenclature committee. Amyloid. 2024;31:249\u201356. https:\/\/doi.org\/10.1080\/13506129.2024.2405948.","journal-title":"Amyloid"},{"key":"659_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583\u201396. https:\/\/doi.org\/10.1056\/NEJMra023144.","journal-title":"N Engl J Med"},{"key":"659_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","volume":"75","author":"F Chiti","year":"2006","unstructured":"Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006;75:333\u201366. https:\/\/doi.org\/10.1146\/annurev.biochem.75.101304.123901.","journal-title":"Annu Rev Biochem"},{"key":"659_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0092-8674(81)90318-4","volume":"24","author":"HL Ploegh","year":"1981","unstructured":"Ploegh HL, Orr HT, Strominger JL. Major histocompatibility antigens: the human (HLA-A,-B,-C) and murine (H-2K, H-2D) class I molecules. Cell. 1981;24:287\u201399. https:\/\/doi.org\/10.1016\/0092-8674(81)90318-4.","journal-title":"Cell"},{"key":"659_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0923-2494(96)89647-7","volume":"147","author":"NE Simister","year":"1996","unstructured":"Simister NE, Creighton J, Ahouse. The structure and evolution of FcRn. Res Immunol. 1996;147:333\u20137. https:\/\/doi.org\/10.1016\/0923-2494(96)89647-7.","journal-title":"Res Immunol"},{"key":"659_CR6","doi-asserted-by":"publisher","unstructured":"Portales-Castillo I, Yee J, Tanaka H, Fenves AZ. Beta-2 microglobulin amyloidosis: past, present, and future, Kidney360 1 (2020) 1447\u201355. https:\/\/doi.org\/10.34067\/KID.0004922020","DOI":"10.34067\/KID.0004922020"},{"key":"659_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0006-291x(85)91948-5","volume":"129","author":"F Gejyo","year":"1985","unstructured":"Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T. A new form of amyloid protein associated with chronic Hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun. 1985;129:701\u20136. https:\/\/doi.org\/10.1016\/0006-291x(85)91948-5.","journal-title":"Biochem Biophys Res Commun"},{"key":"659_CR8","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1056\/NEJMoa1201356","volume":"366","author":"S Valleix","year":"2012","unstructured":"Valleix S, Gillmore JD, Bridoux F, Mangione PP, Dogan A, Nedelec B, Boimard M, Touchard G, Goujon J-M, Lacombe C, Lozeron P, Adams D, Lacroix C, Maisonobe T, Plant\u00e9-Bordeneuve V, Vrana JA, Theis JD, Giorgetti S, Porcari R, Ricagno S, Bolognesi M, Stoppini M, Delpech M, Pepys MB, Hawkins PN, Bellotti V. Hereditary systemic amyloidosis due to Asp76Asn variant \u03b22-microglobulin. N Engl J Med. 2012;366:2276\u201383. https:\/\/doi.org\/10.1056\/NEJMoa1201356.","journal-title":"N Engl J Med"},{"key":"659_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/13506129.2020.1813097","volume":"28","author":"H Mizuno","year":"2021","unstructured":"Mizuno H, Hoshino J, So M, Kogure Y, Fujii T, Ubara Y, Takaichi K, Nakaniwa T, Tanaka H, Kurisu G, Kametani F, Nakagawa M, Yoshinaga T, Sekijima Y, Higuchi K, Goto Y, Yazaki M. Dialysis-related amyloidosis associated with a novel \u03b22-microglobulin variant. Amyloid. 2021;28:42\u20139. https:\/\/doi.org\/10.1080\/13506129.2020.1813097.","journal-title":"Amyloid"},{"key":"659_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/13506129.2022.2072199","volume":"29","author":"T Prokaeva","year":"2022","unstructured":"Prokaeva T, Joshi T, Klimtchuk ES, Gibson VM, Spencer B, Siddiqi O, Nedelkov D, Hu Y, Berk JL, Cuddy SAM, Dasari S, Chiu A, Choate LA, McPhail ED, Cui H, Chen H, Burks EJ, Sanchorawala V, Connors LH. A novel substitution of proline (P32L) destabilises \u03b22-microglobulin inducing hereditary systemic amyloidosis. Amyloid. 2022;29:255\u201362. https:\/\/doi.org\/10.1080\/13506129.2022.2072199.","journal-title":"Amyloid"},{"key":"659_CR11","doi-asserted-by":"publisher","first-page":"ytad239","DOI":"10.1093\/ehjcr\/ytad239","volume":"7","author":"JJ Haslett","year":"2023","unstructured":"Haslett JJ, Patel JK, Kittleson MM. Beta 2-microglobulin: case report of a rare cause of cardiac amyloidosis. Eur Heart J Case Rep. 2023;7:ytad239. https:\/\/doi.org\/10.1093\/ehjcr\/ytad239.","journal-title":"Eur Heart J Case Rep"},{"key":"659_CR12","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.immuni.2021.07.002","volume":"54","author":"D Hofbauer","year":"2021","unstructured":"Hofbauer D, Mougiakakos D, Broggini L, Zaiss M, B\u00fcttner-Herold M, Bach C, Spriewald B, Neumann F, Bisht S, Nolting J, Zeiser R, Hamarsheh S, Eberhardt M, Vera J, Visentin C, De Luca CMG, Moda F, Haskamp S, Flamann C, B\u00f6ttcher M, Bitterer K, V\u00f6lkl S, Mackensen A, Ricagno S, Bruns H. \u03b22-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression. Immunity. 2021;54:1772\u2013e17879. https:\/\/doi.org\/10.1016\/j.immuni.2021.07.002.","journal-title":"Immunity"},{"key":"659_CR13","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1073\/pnas.1008560108","volume":"108","author":"K Domanska","year":"2011","unstructured":"Domanska K, Vanderhaegen S, Srinivasan V, Pardon E, Dupeux F, Marquez JA, Giorgetti S, Stoppini M, Wyns L, Bellotti V, Steyaert J. Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta2-microglobulin variant. Proc Natl Acad Sci U S A. 2011;108:1314\u20139. https:\/\/doi.org\/10.1073\/pnas.1008560108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"659_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/pro.2321","volume":"22","author":"S Vanderhaegen","year":"2013","unstructured":"Vanderhaegen S, Fislage M, Domanska K, Vers\u00e9es W, Pardon E, Bellotti V, Steyaert J. Structure of an early native-like intermediate of \u03b22-microglobulin amyloidogenesis. Protein Sci. 2013;22:1349\u201357. https:\/\/doi.org\/10.1002\/pro.2321.","journal-title":"Protein Sci"},{"key":"659_CR15","doi-asserted-by":"publisher","first-page":"46711","DOI":"10.1038\/srep46711","volume":"7","author":"S Raimondi","year":"2017","unstructured":"Raimondi S, Porcari R, Mangione PP, Verona G, Marcoux J, Giorgetti S, Taylor GW, Ellmerich S, Ballico M, Zanini S, Pardon E, Al-Shawi R, Simons JP, Corazza A, Fogolari F, Leri M, Stefani M, Bucciantini M, Gillmore JD, Hawkins PN, Valli M, Stoppini M, Robinson CV, Steyaert J, Esposito G, Bellotti V. A specific nanobody prevents amyloidogenesis of D76N \u03b22-microglobulin in vitro and modifies its tissue distribution in vivo. Sci Rep. 2017;7:46711. https:\/\/doi.org\/10.1038\/srep46711.","journal-title":"Sci Rep"},{"key":"659_CR16","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.neurobiolaging.2010.09.020","volume":"33","author":"S Kasturirangan","year":"2012","unstructured":"Kasturirangan S, Li L, Emadi S, Boddapati S, Schulz P, Sierks MR. Nanobody specific for oligomeric beta-amyloid stabilizes nontoxic form. Neurobiol Aging. 2012;33:1320\u20138. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.09.020.","journal-title":"Neurobiol Aging"},{"key":"659_CR17","doi-asserted-by":"publisher","first-page":"168320","DOI":"10.1016\/j.jmb.2023.168320","volume":"435","author":"L Broggini","year":"2023","unstructured":"Broggini L, Barzago MM, Speranzini V, Schulte T, Sonzini F, Giono M, Romeo M, Milani P, Caminito S, Mazzini G, Rognoni P, Merlini G, Pappone C, Anastasia L, Nuvolone M, Palladini G, Diomede L, Ricagno S. Nanobodies counteract the toxicity of an amyloidogenic light chain by stabilizing a partially open dimeric conformation. J Mol Biol. 2023;435:168320. https:\/\/doi.org\/10.1016\/j.jmb.2023.168320.","journal-title":"J Mol Biol"},{"key":"659_CR18","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1038\/s41598-024-66970-6","volume":"14","author":"JR Haynes","year":"2024","unstructured":"Haynes JR, Whitmore CA, Behof WJ, Landman CA, Ong HH, Feld AP, Suero IC, Greer CB, Gore JC, Wijesinghe P, Matsubara JA, Wadzinski BE, Spiller BW, Pham W. Targeting soluble amyloid-beta oligomers with a novel nanobody. Sci Rep. 2024;14:16086. https:\/\/doi.org\/10.1038\/s41598-024-66970-6.","journal-title":"Sci Rep"},{"key":"659_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.tibtech.2017.04.007","volume":"35","author":"S St\u00e5hl","year":"2017","unstructured":"St\u00e5hl S, Gr\u00e4slund T, Eriksson A, Karlstr\u00f6m FY, Frejd P-\u00c5, Nygren J, L\u00f6fblom. Affibody molecules in biotechnological and medical applications. Trends Biotechnol. 2017;35:691\u2013712. https:\/\/doi.org\/10.1016\/j.tibtech.2017.04.007.","journal-title":"Trends Biotechnol"},{"key":"659_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nbt0897-772","volume":"15","author":"K Nord","year":"1997","unstructured":"Nord K, Gunneriusson E, Ringdahl J, St\u00e5hl S, Uhl\u00e9n M, Nygren PA. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nat Biotechnol. 1997;15:772\u20137. https:\/\/doi.org\/10.1038\/nbt0897-772.","journal-title":"Nat Biotechnol"},{"key":"659_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-61779-921-1_7","volume":"899","author":"J Feldwisch","year":"2012","unstructured":"Feldwisch J, Tolmachev V. Engineering of affibody molecules for therapy and diagnostics. Methods Mol Biol. 2012;899:103\u201326. https:\/\/doi.org\/10.1007\/978-1-61779-921-1_7.","journal-title":"Methods Mol Biol"},{"key":"659_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13550-020-0603-9","volume":"10","author":"A Alhuseinalkhudhur","year":"2020","unstructured":"Alhuseinalkhudhur A, Lubberink M, Lindman H, Tolmachev V, Frejd FY, Feldwisch J, Velikyan I, S\u00f6rensen J. Kinetic analysis of HER2-binding ABY-025 affibody molecule using dynamic PET in patients with metastatic breast cancer. EJNMMI Res. 2020;10:21. https:\/\/doi.org\/10.1186\/s13550-020-0603-9.","journal-title":"EJNMMI Res"},{"key":"659_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/bjd\/ljad186","volume":"189","author":"S Gerdes","year":"2023","unstructured":"Gerdes S, Staubach P, Dirschka T, Wetzel D, Weirich O, Niesmann J, da Mota R, Rothhaar A, Ardabili M, Vlasitz G, Feldwisch J, Osterling Koskinen L, Ohlman S, Peloso PM, Brun NC, Frejd FY. Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment. Br J Dermatol. 2023;189:381\u201391. https:\/\/doi.org\/10.1093\/bjd\/ljad186.","journal-title":"Br J Dermatol"},{"key":"659_CR24","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1158\/1535-7163.MCT-09-0195","volume":"8","author":"MM Schmidt","year":"2009","unstructured":"Schmidt MM, Wittrup KD. A modeling analysis of the effects of molecular size and binding affinity on tumor targeting. Mol Cancer Ther. 2009;8:2861\u201371. https:\/\/doi.org\/10.1158\/1535-7163.MCT-09-0195.","journal-title":"Mol Cancer Ther"},{"key":"659_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jbiotec.2006.09.013","volume":"128","author":"C Gr\u00f6nwall","year":"2007","unstructured":"Gr\u00f6nwall C, Jonsson A, Lindstr\u00f6m S, Gunneriusson E, St\u00e5hl S, Herne N. Selection and characterization of affibody ligands binding to alzheimer amyloid \u0392 peptides. J Biotechnol. 2007;128:162\u201383. https:\/\/doi.org\/10.1016\/j.jbiotec.2006.09.013.","journal-title":"J Biotechnol"},{"key":"659_CR26","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/biot.201500131","volume":"10","author":"H Lindberg","year":"2015","unstructured":"Lindberg H, H\u00e4rd T, L\u00f6fblom J, St\u00e5hl S. A truncated and dimeric format of an affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity. Biotechnol J. 2015;10:1707\u201318. https:\/\/doi.org\/10.1002\/biot.201500131.","journal-title":"Biotechnol J"},{"key":"659_CR27","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1038\/s41598-017-06377-8","volume":"7","author":"E Wahlberg","year":"2017","unstructured":"Wahlberg E, Rahman MM, Lindberg H, Gunneriusson E, Schmuck B, Lendel C, Sandgren M, L\u00f6fblom J, St\u00e5hl S, H\u00e4rd T. Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-\u03b2. Sci Rep. 2017;7:5949. https:\/\/doi.org\/10.1038\/s41598-017-06377-8.","journal-title":"Sci Rep"},{"key":"659_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ijbiomac.2021.07.056","volume":"186","author":"P Salahuddin","year":"2021","unstructured":"Salahuddin P, Khan RH, Furkan M, Uversky VN, Islam Z, Fatima MT. Mechanisms of amyloid proteins aggregation and their Inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies. Int J Biol Macromol. 2021;186:580\u201390. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.07.056.","journal-title":"Int J Biol Macromol"},{"key":"659_CR29","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.jmb.2008.03.002","volume":"378","author":"G Esposito","year":"2008","unstructured":"Esposito G, Ricagno S, Corazza A, Rennella E, G\u00fcmral D, Mimmi MC, Betto E, Pucillo CEM, Fogolari F, Viglino P, Raimondi S, Giorgetti S, Bolognesi B, Merlini G, Stoppini M, Bolognesi M, Bellotti V. The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. J Mol Biol. 2008;378:887\u201397. https:\/\/doi.org\/10.1016\/j.jmb.2008.03.002.","journal-title":"J Mol Biol"},{"key":"659_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s42256-023-00778-3","volume":"6","author":"A Ramon","year":"2024","unstructured":"Ramon A, Ali M, Atkinson M, Saturnino A, Didi K, Visentin C, Ricagno S, Xu X, Greenig M, Sormanni P. Assessing antibody and nanobody nativeness for hit selection and humanization with abnativ. Nat Mach Intell. 2024;6:74\u201391. https:\/\/doi.org\/10.1038\/s42256-023-00778-3.","journal-title":"Nat Mach Intell"},{"key":"659_CR31","doi-asserted-by":"publisher","first-page":"e81350","DOI":"10.1371\/journal.pone.0081350","volume":"8","author":"J Seijsing","year":"2013","unstructured":"Seijsing J, Lindborg M, L\u00f6fblom J, Uhl\u00e9n M, Gr\u00e4slund T. Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP. PLoS ONE. 2013;8:e81350. https:\/\/doi.org\/10.1371\/journal.pone.0081350.","journal-title":"PLoS ONE"},{"key":"659_CR32","doi-asserted-by":"publisher","first-page":"17110","DOI":"10.1073\/pnas.1417717111","volume":"111","author":"J Seijsing","year":"2014","unstructured":"Seijsing J, Lindborg M, H\u00f6id\u00e9n-Guthenberg I, B\u00f6nisch H, Guneriusson E, Frejd FY, Abrahms\u00e9n L, Ekblad C, L\u00f6fblom J, Uhl\u00e9n M, Gr\u00e4slund T. An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein. Proc Natl Acad Sci U S A. 2014;111:17110\u20135. https:\/\/doi.org\/10.1073\/pnas.1417717111.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"659_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbapap.2005.06.005","volume":"1751","author":"SM Kelly","year":"2005","unstructured":"Kelly SM, Jess TJ, Price NC. How to study proteins by circular dichroism. Biochim Biophys Acta. 2005;1751:119\u201339. https:\/\/doi.org\/10.1016\/j.bbapap.2005.06.005.","journal-title":"Biochim Biophys Acta"},{"key":"659_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard AJ, Bambrick J, Bodenstein SW, Evans DA, Hung C-C, O\u2019Neill M, Reiman D, Tunyasuvunakool K, Wu Z, \u017demgulyt\u0117 A, Arvaniti E, Beattie C, Bertolli O, Bridgland A, Cherepanov A, Congreve M, Cowen-Rivers AI, Cowie A, Figurnov M, Fuchs FB, Gladman H, Jain R, Khan YA, Low CMR, Perlin K, Potapenko A, Savy P, Singh S, Stecula A, Thillaisundaram A, Tong C, Yakneen S, Zhong ED, Zielinski M, \u017d\u00eddek A, Bapst V, Kohli P, Jaderberg M, Hassabis D, Jumper JM. Accurate structure prediction of biomolecular interactions with alphafold 3. Nature. 2024;630:493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w.","journal-title":"Nature"},{"key":"659_CR35","doi-asserted-by":"publisher","first-page":"9951","DOI":"10.1074\/jbc.R115.639799","volume":"290","author":"M Stoppini","year":"2015","unstructured":"Stoppini M, Bellotti V. Lessons from \u03b22-Microglobulin*. J Biol Chem. 2015;290:9951\u20138. https:\/\/doi.org\/10.1074\/jbc.R115.639799.","journal-title":"J Biol Chem"},{"key":"659_CR36","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1038\/s41467-018-06761-6","volume":"9","author":"MG Iadanza","year":"2018","unstructured":"Iadanza MG, Silvers R, Boardman J, Smith HI, Karamanos TK, Debelouchina GT, Su Y, Griffin RG, Ranson NA, Radford SE. The structure of a \u03b22-microglobulin fibril suggests a molecular basis for its amyloid polymorphism. Nat Commun. 2018;9:4517. https:\/\/doi.org\/10.1038\/s41467-018-06761-6.","journal-title":"Nat Commun"},{"key":"659_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nsb791","volume":"9","author":"VJ McParland","year":"2002","unstructured":"McParland VJ, Kalverda AP, Homans SW, Radford SE. Structural properties of an amyloid precursor of beta(2)-microglobulin. Nat Struct Biol. 2002;9:326\u201331. https:\/\/doi.org\/10.1038\/nsb791.","journal-title":"Nat Struct Biol"},{"key":"659_CR38","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/cncr.24959","volume":"116","author":"D Rossi","year":"2010","unstructured":"Rossi D, Fangazio M, De Paoli L, Puma A, Riccomagno P, Pinto V, Zigrossi P, Ramponi A, Monga G, Gaidano G. Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma. Cancer. 2010;116:2188\u2013200. https:\/\/doi.org\/10.1002\/cncr.24959.","journal-title":"Cancer"},{"key":"659_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2147\/IJNRD.S84784","volume":"9","author":"R Scarpioni","year":"2016","unstructured":"Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis. 2016;9:319\u201328. https:\/\/doi.org\/10.2147\/IJNRD.S84784.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"659_CR40","doi-asserted-by":"publisher","first-page":"17077","DOI":"10.1021\/ja107987f","volume":"132","author":"GT Debelouchina","year":"2010","unstructured":"Debelouchina GT, Platt GW, Bayro MJ, Radford SE, Griffin RG. Intermolecular alignment in \u03b22-Microglobulin amyloid fibrils. J Am Chem Soc. 2010;132:17077\u20139. https:\/\/doi.org\/10.1021\/ja107987f.","journal-title":"J Am Chem Soc"},{"key":"659_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1110\/ps.051817606","volume":"15","author":"RJ Hosse","year":"2006","unstructured":"Hosse RJ, Rothe A, Power BE. A new generation of protein display scaffolds for molecular recognition. Protein Sci. 2006;15:14\u201327. https:\/\/doi.org\/10.1110\/ps.051817606.","journal-title":"Protein Sci"},{"key":"659_CR42","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1110\/ps.9.5.831","volume":"9","author":"G Esposito","year":"2000","unstructured":"Esposito G, Michelutti R, Verdone G, Viglino P, \u00c1Ndez HH, Robinson CV, Amoresano A, Piaz FD, Monti M, Pucci P, Mangione P, Stoppini M, Merlini G, Ferri G, Bellotti V. Removal of the N-terminal hexapeptide from human \u03b22-microglobulin facilitates protein aggregation and fibril formation. Protein Sci. 2000;9:831\u201345. https:\/\/doi.org\/10.1110\/ps.9.5.831.","journal-title":"Protein Sci"},{"key":"659_CR43","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.bbrc.2009.01.116","volume":"380","author":"S Ricagno","year":"2009","unstructured":"Ricagno S, Raimondi S, Giorgetti S, Bellotti V, Bolognesi M. Human beta-2 microglobulin W60V mutant structure: implications for stability and amyloid aggregation. Biochem Biophys Res Commun. 2009;380:543\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2009.01.116.","journal-title":"Biochem Biophys Res Commun"},{"key":"659_CR44","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1111\/j.1742-4658.2011.08157.x","volume":"278","author":"S Azinas","year":"2011","unstructured":"Azinas S, Colombo M, Barbiroli A, Santambrogio C, Giorgetti S, Raimondi S, Bonomi F, Grandori R, Bellotti V, Ricagno S, Bolognesi M. D-strand perturbation and amyloid propensity in beta-2 microglobulin. FEBS J. 2011;278:2349\u201358. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08157.x.","journal-title":"FEBS J"},{"key":"659_CR45","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.bpj.2012.02.045","volume":"102","author":"D Ami","year":"2012","unstructured":"Ami D, Ricagno S, Bolognesi M, Bellotti V, Doglia SM, Natalello A. Structure, stability, and aggregation of \u03b2-2 microglobulin Mutants: insights from a fourier transform infrared study in solution and in the crystalline state. Biophys J. 2012;102:1676\u201384. https:\/\/doi.org\/10.1016\/j.bpj.2012.02.045.","journal-title":"Biophys J"},{"key":"659_CR46","doi-asserted-by":"publisher","first-page":"25559","DOI":"10.1038\/srep25559","volume":"6","author":"C Camilloni","year":"2016","unstructured":"Camilloni C, Sala BM, Sormanni P, Porcari R, Corazza A, De Rosa M, Zanini S, Barbiroli A, Esposito G, Bolognesi M, Bellotti V, Vendruscolo M, Ricagno S. Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability. Sci Rep. 2016;6:25559. https:\/\/doi.org\/10.1038\/srep25559.","journal-title":"Sci Rep"}],"updated-by":[{"DOI":"10.1186\/s13062-025-00679-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000}}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00659-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-025-00659-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00659-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:06:50Z","timestamp":1752764810000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-025-00659-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["659"],"URL":"https:\/\/doi.org\/10.1186\/s13062-025-00659-2","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13062-025-00679-y","asserted-by":"object"}]},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13062-025-00679-y","URL":"https:\/\/doi.org\/10.1186\/s13062-025-00679-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"67"}}